Official websites use .gov
Secure .gov websites use HTTPS
« Previous
Next »
Titles
- R&D programs 19861
- REMS: FDA's application of statutory factors in determining when a REMS is necessary1
- Race suicide1
- Racial and ethnic differences in children's mental health services in Medicaid before and during the COVID-19 pandemic1
- Racial and ethnic health disparities1
- Radiology in World War II1
- Ralph Waldo Emerson1
- Rank in the Navy: speech of Hon. Aaron F. Stevens, of New Hampshire, delivered in the House of Representatives, January 23, 18711
- Rare diseases: Although limited, available evidence suggests medical and other costs can be substantial : report to congressional committees1
- Rare diseases: considerations for the development of drugs and biological products : guidance for industry1
- Re-enlistments for one, two, and three years1
- Reaching the remaining uninsured: an evidence review on outreach & enrollment1
- Read it before you eat it!1
- Reagents and volumetric solutions proposed for the U.S. Pharmacopoeia, together with some specimens of the text proposed1
- Real-time oncology review (RTOR): guidance for industry1
- Real-world data: assessing registries to support regulatory decision-making for drug and biological products : guidance for industry1
- Rear Admiral Goldsborough and the retiring laws of the Navy1
- Rebalancing long-term care: the role of the Medicaid HCBS waiver program1
- Rebates for brand-name drugs in Part D substantially reduced the growth in spending from 2011 to 20151
- Recapitulation of all Veterans Administration bed-producing projects: existing hospitals and homes and transferred military and other hospitals in operation or approved1